Avista Healthcare

Chatsworth, California; Baar-Zug, Switzerland; New York, New York, September 6, 2012 – Strategic Partners’ management team, Partners Group, the global private markets investment manager, and Avista Capital Partners (“Avista”), a leading private equity firm, today announced they have closed on the acquisition of Strategic Partners, Inc. (“Strategic Partners”). Strategic Partners is a leader in the […]

Skillman, NJ – August 31, 2012 – ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has entered into a definitive agreement to acquire all of the capital stock of 180 Medical Holdings, Inc. (“180 Medical”) for $321 million. 180 Medical is a leading U.S. provider […]

May 2, 2012 – A consortium of private equity funds led by Nordic Capital Funds V and VI (”Nordic Capital”), including DLJ Merchant Banking Partners (a Credit Suisse affiliate) and Avista Capital Partners, today announced a definitive agreement to sell Fougera Pharmaceuticals Inc. (“Fougera” or “the Company”) to Sandoz, the generics division of Novartis, at […]

London, UK – March 2, 2012 – ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care today announced that Amcare Ltd, a wholly-owned subsidiary of ConvaTec Holdings UK Ltd, has acquired SureCalm Healthcare Holdings Ltd and subsidiaries (“SureCalm Healthcare”), a UK-based homecare services group that specialises in the home […]

Raleigh, N.C., Feb. 29, 2012 – INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the Company has received the “most consistent service quality ratings of all the companies profiled” in the 2012 CRO Quality Benchmarking Report published by Industry Standard Research (ISR). For […]

Increases Scale in Vascular Access and Peripheral Vascular Markets Expands Product Portfolio and Adds Innovative Technologies Strengthens Focus on Operational Excellence Expected to be Accretive in FY13 ALBANY, N.Y. and MARLBOROUGH, Mass., Jan. 31, 2012 – (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral […]

Rockville, MD, USA – January 9, 2012 – BioReliance, a leading provider of global biopharmaceutical testing services, announced today that it has agreed to be acquired by Sigma-Aldrich Corporation (NASDAQ:SIAL). Avista Capital Partners, the majority owner of BioReliance Holdings, Inc., agreed to sell the company for $350 million in cash. The acquisition is subject to […]

Departing Nycomed CEO Bolsters Leading Private Equity Healthcare Practice New York, NY, October 3, 2011 – Avista Capital Partners, a leading private equity firm, today announced that it has hired Håkan Björklund, the departing Chief Executive Officer of Nycomed, as Healthcare Operating Executive. Mr. Björklund worked closely with Avista on the development of Nycomed during […]

OSAKA, Japan, September 30, 2011 – Takeda Pharmaceutical Company Limited (“Takeda”, TSE: 4502) announced it has completed its acquisition of Nycomed A/S (“Nycomed”) for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary of Takeda effective the same day. Dr. Frank Morich has been named CEO of Nycomed in […]

Skillman, NJ, September 1, 2011 – ConvaTec Inc., a world-leading developer and marketer of innovative medical technologies for community and hospital care today announced that the company has acquired Boston Medical Device, Inc. (BMD), a distribution company that offers a platform of specialized medical devices throughout Latin America. More than 30 years of management experience […]

by John George Philadelphia Business Journal Yardley, PA, June 3, 2011 – Peter Miller was sniffing around for his next entrepreneurial opportunity last summer when he decided to join OptiNose as CEO of the Bucks County company that has developed a new way to deliver medicine. “I fell in love with two things,” said Miller, […]

OSAKA, Japan, and ZURICH, Switzerland, May 19, 2011 – Takeda Pharmaceutical Company Limited (“Takeda”, TSE: 4502) and Nycomed A/S (“Nycomed”) jointly announced today that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the Zurich-headquartered company for 9.6 billion Euro on a cash-free, debt-free basis. The boards of directors […]